PURPOSE: Universal anti-hepatitis B vaccination of infants and of 12-year-old children became mandatory in Italy in 1991. The purpose of this study was to evaluate the persistence of anti-hepatitis B surface (HBs) antibodies several years after a primary course of vaccination. METHODS: In 2010, anti-HBs titers were measured in all subjects aged between 5 and 25 years residing in a southern Italian town. Individuals with an anti-hepatitis B antibody concentration of 10 IU/ml or more were considered to be protected. RESULTS: Of the 671 subjects evaluated, 149 (30%) lacked protective antibodies. Fifty-three (29.4%) of the subjects had been vaccinated ≤10 years earlier and 96 (30.3%) more than 10 years earlier (P = not significant). Subjects vaccinated in infancy were more likely to lack protective anti-HBs antibodies than subjects vaccinated at 12 years of age, regardless of the years elapsed since immunization. CONCLUSIONS: Most subjects maintained protective antibodies for a considerable number of years after vaccination. Vaccination in adolescence results in more prolonged immunogenicity than vaccination in infancy.
PURPOSE: Universal anti-hepatitis B vaccination of infants and of 12-year-old children became mandatory in Italy in 1991. The purpose of this study was to evaluate the persistence of anti-hepatitis B surface (HBs) antibodies several years after a primary course of vaccination. METHODS: In 2010, anti-HBs titers were measured in all subjects aged between 5 and 25 years residing in a southern Italian town. Individuals with an anti-hepatitis B antibody concentration of 10 IU/ml or more were considered to be protected. RESULTS: Of the 671 subjects evaluated, 149 (30%) lacked protective antibodies. Fifty-three (29.4%) of the subjects had been vaccinated ≤10 years earlier and 96 (30.3%) more than 10 years earlier (P = not significant). Subjects vaccinated in infancy were more likely to lack protective anti-HBs antibodies than subjects vaccinated at 12 years of age, regardless of the years elapsed since immunization. CONCLUSIONS: Most subjects maintained protective antibodies for a considerable number of years after vaccination. Vaccination in adolescence results in more prolonged immunogenicity than vaccination in infancy.
Authors: V Guadagnino; T Stroffolini; M Rapicetta; A Costantino; L A Kondili; F Menniti-Ippolito; B Caroleo; C Costa; G Griffo; L Loiacono; V Pisani; A Focà; M Piazza Journal: Hepatology Date: 1997-10 Impact factor: 17.425
Authors: T Stroffolini; A Mele; M E Tosti; G Gallo; E Balocchini; P Ragni; F Santonastasi; A Marzolini; M Ciccozzi; A Moiraghi Journal: J Hepatol Date: 2000-12 Impact factor: 25.083
Authors: Brian J McMahon; Dana L Bruden; Kenneth M Petersen; Lisa R Bulkow; Alan J Parkinson; Omana Nainan; Marina Khristova; Carolyn Zanis; Helen Peters; Harold S Margolis Journal: Ann Intern Med Date: 2005-03-01 Impact factor: 25.391
Authors: T Stroffolini; V Guadagnino; P Chionne; B Procopio; E G Mazzuca; F Quintieri; P Scerbo; A Giancotti; S Nisticò; A Focà; M E Tosti; M Rapicetta Journal: Ital J Gastroenterol Hepatol Date: 1997-10
Authors: Britta Höcker; Martin Aguilar; Paul Schnitzler; Lars Pape; Martin Bald; Jens König; Stephen D Marks; Gurkan Genc; Anja Büscher; Markus J Kemper; Heiko Billing; Martin Pohl; Luca Dello Strologo; Nicholas J A Webb; Susanne Rieger; Annette Mankertz; Kai Krupka; Thomas Bruckner; Alexander Fichtner; Burkhard Tönshoff Journal: Pediatr Nephrol Date: 2018-01-10 Impact factor: 3.714
Authors: Monica Lamberti; Alfredo De Rosa; Elpidio Maria Garzillo; Anna Rita Corvino; Nicola Sannolo; Stefania De Pascalis; Eliana Di Fiore; Claudia Westermann; Antonio Arnese; Di Giuseppe Gabriella; Albert Nienhaus; Antônio Paulino Ribeiro Sobrinho; Nicola Coppola Journal: J Occup Med Toxicol Date: 2015-11-04 Impact factor: 2.646